Finance

Lists
Q3 2026 earnings • released • EPS miss -1,370.16%
See results
TRXB:NASDAQ
TRex Bio, Inc.
$13.67
-3.05%
(-0.43) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRXB...
Open
$14.10
High
$14.10
Low
$13.32
Mkt. cap
375.18M
Avg. vol.
128.90K
Volume
62.68K
52-wk high
$16.56
52-wk low
$12.50
EPS
-$1.69
No. of employees
60
Open
$14.10
High
$14.10
Low
$13.32
Mkt. cap
375.18M
Avg. vol.
128.90K
Volume
62.68K
52-wk high
$16.56
52-wk low
$12.50
EPS
-$1.69
No. of employees
60
News stories
From web sources and news partners
About TRex Bio, Inc.
CEO-
Employees60
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitetrex.bio
Analyst ratings
Based on 4 analysts giving stock ratings to TRXB in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TRXB in the last 3 months.
Highest
Current $13.67
$39.00 (+185.30%)
Average
$30.00 (+119.46%)
Lowest
$20.00 (+46.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
$31.00
+126.8%
11/03/2026
Brian Cheng
J.P. Morgan
Buy
Initiated
$20.00
+46.3%
11/03/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Initiated
$39.00
+185.3%
11/03/2026
Martin Fan
Wedbush
Buy
Initiated
$30.00
+119.5%
11/02/2026
Last report
Nov 13, 2026
Fiscal period
Q3 2026
-$10.06 / -$0.68
-1,370.16%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.48M
7.48M
13.02M
13.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.13M
2.13M
2.49M
2.49M
Operating expense
9.61M
9.61M
15.51M
15.51M
Total operating expenses
9.61M
9.61M
15.51M
15.51M
Operating income
-9.61M
-9.61M
-15.51M
-15.51M
Other non operating income
-33.00K
-33.00K
-1.50K
-1.50K
EBT including unusual items
-8.86M
-8.86M
-14.63M
-14.63M
EBT excluding unusual items
-8.86M
-8.86M
-14.63M
-14.63M
Income tax expense
-
-
21.00K
21.00K
Effective tax rate
-
-
-0.14%
-0.14%
Other operating expenses
-
-
-
-
Net income
-8.86M
-8.86M
-14.65M
-14.65M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
784.00K
784.00K
877.50K
877.50K
Interest expense
-
-
-
-
Net interest expenses
784.00K
784.00K
877.50K
877.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.56M
-9.56M
-15.45M
-15.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps